Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brough

Showing results (481-490 of 871) with videos related to

Pageof 88
Sort By:
Cell Reports|February 2, 2018
Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast CancerAgnieszka K Witkiewicz, Sejin Chung, Rachel Brough, et al.
Immunology|May 24, 2020
Hallmarks of NLRP3 inflammasome activation are observed in organotypic hippocampal slice cultureChristopher Hoyle, Elena Redondo-Castro, James Cook, et al.
Journal of Virology|November 26, 1997
Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivoD E Brough, C Hsu, V A Kulesa, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|November 8, 2005
Long-term functional outcomes and academic-occupational status in implanted children after 10 to 14 years of cochlear implant useElizabeth A R Beadle, Dyan J McKinley, Thomas P Nikolopoulos, et al.
Chemmedchem|January 14, 2018
Design, Synthesis and Evaluation of Oxazaborine Inhibitors of the NLRP3 InflammasomeAlex G Baldwin, Victor S Tapia, Tessa Swanton, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 22, 2026
Nutritional, Growth, and Microbiome Implications of Oral Immunotherapy: Unintended Consequences and Clinical ConsiderationsCarina Venter, Klaudia Ryczaj, Allison G Hicks, et al.
British Journal of Pharmacology|March 17, 2001
SB-334867-A: the first selective orexin-1 receptor antagonistD Smart, C Sabido-David, S J Brough, et al.
Human Mutation|February 1, 2012
Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cellsRudolf Arlanov, Andrew Porter, Dennis Strand, et al.
European Journal of Pharmacology|March 7, 2001
Pharmacological characterisation of human 5-HT2 receptor subtypesJ C Jerman, S J Brough, T Gager, et al.
Disability and Rehabilitation. Assistive Technology|March 10, 2025
Assistive technology at work: a metasynthesis of the perspectives of people with spinal cord injury/damageJessie Mitchell, Jessica O'Loghlen, Emily Bray, et al.
Pageof 88

Showing results (481-490 of 871) with videos related to

Sort By:
Pageof 88
Cell Reports|February 2, 2018
Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast CancerAgnieszka K Witkiewicz, Sejin Chung, Rachel Brough, et al.
Immunology|May 24, 2020
Hallmarks of NLRP3 inflammasome activation are observed in organotypic hippocampal slice cultureChristopher Hoyle, Elena Redondo-Castro, James Cook, et al.
Journal of Virology|November 26, 1997
Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivoD E Brough, C Hsu, V A Kulesa, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|November 8, 2005
Long-term functional outcomes and academic-occupational status in implanted children after 10 to 14 years of cochlear implant useElizabeth A R Beadle, Dyan J McKinley, Thomas P Nikolopoulos, et al.
Chemmedchem|January 14, 2018
Design, Synthesis and Evaluation of Oxazaborine Inhibitors of the NLRP3 InflammasomeAlex G Baldwin, Victor S Tapia, Tessa Swanton, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 22, 2026
Nutritional, Growth, and Microbiome Implications of Oral Immunotherapy: Unintended Consequences and Clinical ConsiderationsCarina Venter, Klaudia Ryczaj, Allison G Hicks, et al.
British Journal of Pharmacology|March 17, 2001
SB-334867-A: the first selective orexin-1 receptor antagonistD Smart, C Sabido-David, S J Brough, et al.
Human Mutation|February 1, 2012
Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cellsRudolf Arlanov, Andrew Porter, Dennis Strand, et al.
European Journal of Pharmacology|March 7, 2001
Pharmacological characterisation of human 5-HT2 receptor subtypesJ C Jerman, S J Brough, T Gager, et al.
Disability and Rehabilitation. Assistive Technology|March 10, 2025
Assistive technology at work: a metasynthesis of the perspectives of people with spinal cord injury/damageJessie Mitchell, Jessica O'Loghlen, Emily Bray, et al.
Pageof 88